U.S. task force raises doubts on youth suicide screening
An influential U.S. group is raising doubts about routine suicide screening for children and teens…
Author: STAT
Ransomware hits rural health centers & a true test of AI
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: U.K. readies a Netflix-style subscription payment model for badly needed antibiotics
Amid rising concern over antimicrobial resistance, the U.K. has taken a major step toward becoming…
Driven by fentanyl, rates of fatal teen overdoses doubled in 2020
After staying flat for a decade, the overdose death rate among U.S. adolescents nearly doubled…
STAT+: Pharmalittle: Will Biogen sue CMS over Alzheimer’s drug coverage? Novartis plans to lay off thousands
Hello, everyone, and how are you this morning? A spot of rain is falling on…
Opinion: Amid the nation’s mental health crisis, we need more psychiatrists now
Every day, people call my office looking for help: A loved one has not left…
.jpg)
Opinion: As a pain specialist, I may have caused more harm by underprescribing opioids
A reporter recently asked me about what harm I may have caused as a pain…
STAT+: Will Biogen sue Medicare over its restrictions on the Alzheimer’s drug, Aduhelm? And other big legal questions about the decision
WASHINGTON — Biogen and other drugmakers have already hinted they might sue Medicare over its…
Human Rights Watch says unaffordable U.S. insulin is a human rights abuse
WASHINGTON — Insulin prices are sky high. High enough, now, that Human Rights Watch is…
STAT+: New bipartisan insulin policy aims to entice drugmakers to lower prices
WASHINGTON — A bipartisan group of four key lawmakers unveiled a long-shot policy that aims…
After accusations of structural racism at JAMA, a Black health-equity advocate is named the journal’s editor
A year after the prestigious medical journal JAMA was embroiled in controversy over a podcast…
STAT+: FDA scolds Bausch Health for misleading claims about a psoriasis cream
The U.S. Food and Drug Administration has scolded Bausch Health for a video and webpage…
STAT+: Giving immunotherapy before surgery prevents lung cancer from returning, study says
Giving the immunotherapy Opdivo, made by Bristol-Myers Squibb, to lung cancer patients before surgery can…
STAT+: Pharmalittle: Lilly and Eisai will still seek accelerated approval for Alzheimer’s drugs; CAR-T cells may shrink some solid tumors
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Private equity giant Carlyle to acquire biotech venture capital firm Abingworth
The Carlyle Group will acquire Abingworth, one of biotech’s oldest venture capital groups, it announced…
Opinion: The power of inclusion: Overturning the ‘white wall’ standard
Have you ever walked down a long hallway in a building and noticed the uniformity…
Opinion: The ‘successful failures’ of Apollo 13 and Covid-19 vaccination
Doomed from the start. That phrase neatly describes the Apollo 13 mission, which launched this…
At small and rural hospitals, ransomware attacks are causing unprecedented crises
At 12:08 p.m. on a Monday, a Sky Lakes Medical Center employee tapped an email…
An mRNA vaccine boost may help CAR T-therapy treat solid cancers
NEW ORLEANS — While CAR T-therapy has cured some people with blood cancers, this form…
STAT+: Natural killer cells, primed with an antibody, induce remissions in patients with advanced lymphoma
An experimental immunotherapy involving so-called natural killer cells elicited complete remissions in a majority of…
STAT+: Lighting up cancer cells with pH-activated nanoparticles
On a screen at the American Association of Cancer Research (AACR) conference on Saturday, one…
Opinion: The ‘bot holiday’ and why clinicians can’t tackle disinformation alone
The war in Ukraine has had an unexpected side effect noted by many health care…
STAT+: ‘Precedents are important’: Aduhelm coverage restrictions could shape the future of accelerated approval
Whither accelerated approval? Amid the hubbub over new Medicare coverage restrictions for Alzheimer’s treatments, a…
Opinion: CMS made the wrong decision on Aduhelm. But there might be a silver lining
The Centers for Medicare and Medicaid Services (CMS) issued on Thursday its hotly debated final…
STAT+: Warren, Grassley threaten to slap FDA with a 30-day deadline for OTC hearing aid rules
WASHINGTON – A bipartisan duo of senators is done waiting for the Food and Drug…
STAT+: Pharmalittle: Medicare finalizes plan for controversial Alzheimer’s drug; advocacy group faces controversy over CMS proposal
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Averting the looming purge of people from Medicaid
Up to 16 million Americans on Medicaid, the federal-state program that provides health care to…
STAT+: For patients, seeing the benefits of the new, fully sequenced genome could take years
Genomics has made significant inroads into mainstream medicine — DNA data are now routinely used…
STAT+: Biden’s new high-stakes research agency needs a home. For cities and states, the race for ARPA-H is on
WASHINGTON — The Biden administration’s new high-stakes research office has a name, an official place…
Medicare finalizes its restrictions on new Alzheimer’s drug, despite pressure from drugmakers
WASHINGTON — Medicare on Thursday finalized its plan to restrict coverage for the controversial, pricey…
STAT+: Advocacy group’s advisory board members defect over Biogen Alzheimer’s drug
The furious debate over Biogen’s Alzheimer’s treatment has now sparked controversy over the Alliance for…
Listen: What’s next for Roche, a debate over second boosters, & Vertex’s recent success
What’s on tap for Roche and its closely followed cancer immunotherapy? Are we all headed…
STAT+: Pharmalittle: Low-income Part D beneficiaries without subsidies often don’t fill scripts; Pfizer strikes a deal for RSV drugs
Hello, everyone, and how are you today? Gray skies are hovering over the chilly Pharmalot…
Opinion: 3 steps ARPA-H needs to take to accomplish its mission
Since its formation in the 1950s, the Defense Advanced Research Projects Agency, better known as…
Opinion: The organ procurement system is failing people of color like me. It’s time for reform
I am a Black woman who has been waiting for seven years for a kidney…
‘We are not casting a wide enough net’: Rob Perez on how biopharma companies can help out their neighbors
If it wasn’t for a well-placed ad in the paper, Rob Perez might not have…
STAT+: A new crop of companies is reshaping the health data economy
It is one of health care’s most vexing quandaries: Patient data must be shared to…
STAT+: Many Medicare Part D beneficiaries don’t fill prescriptions for high-priced medicines
Medicare Part D beneficiaries who have low incomes and receive government subsidies were nearly twice…
Opinion: Report: U.S. nursing home care is ineffective, inefficient, inequitable, fragmented, and unsustainable
Nursing homes have been at the epicenter of the pandemic, though they have fallen off…
STAT+: Pharmalittle: Most Americans would get a second booster shot; FDA pulls Glaxo Covid treatment
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
Tracking an FDA advisory panel meeting on Covid-19 vaccines and boosters
When the Food and Drug Administration last month announced it would be holding another meeting…
Opinion: STAT+: Reimagining R&D can cut drug development costs from billions to millions
In the course of our work advising biopharma companies, we are often asked how they…
Opinion: Listen: Should gender dysphoria be a required stop en route to gender euphoria?
For trans people who want to receive gender-affirming medical care such as hormone treatments or…
‘We need to be much more diverse’: More than half of data used in health care AI comes from the U.S. and China
As medicine continues to test automated machine learning tools, many hope that low-cost support tools…
STAT+: Virtual reality in medicine is garnering more investment. Will the health care system buy in?
As tech companies raise billions of venture capital dollars and completely rebrand to build out…
STAT+: STAT-Harris Poll: Most Americans would get a Covid-19 booster shot if recommended
As a Food and Drug Administration panel meets Wednesday to sort out the ongoing use…
Biden administration ramps up long Covid research efforts following criticism
WASHINGTON — The Biden administration on Tuesday announced plans to ramp up research into long…
‘All the shrapnel that’s in my back’: Defiant Robert Redfield blasts former CDC directors for criticism during Covid-19
A defiant Robert Redfield teed off on other former directors of the Centers for Disease…
Health tech funding and stock prices slipped in the first quarter
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Colombian government faces calls to issue compulsory license for Pfizer’s Covid-19 pill
In the latest bid to expand access to the Pfizer Covid-19 pill, several advocacy groups…